Read + Share
Amedeo Smart
Independent Medical Education
Chaft JE, Oezkan F, Kris MG, Bunn PA, et al. Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial. Nat Med 2022 Sep 12. pii: 10.1038/s41591-022-01962.PMID: 36097216
Email
LinkedIn
Facebook
Twitter
Privacy Policy